Delivery Order SPE2DB24D3015-SPE2DB25FGAMW
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for TYPHIM VI 25 MCG/0.5 ML syringes valued at $1,379.80 with a firm fixed price structure. This is a non-set-aside, competitively awarded contract with performance scheduled for completion by July 25, 2025, at AmerisourceBergen's facility in Conshohocken, Pennsylvania. TYPHIM VI is a typhoid vaccine used by the Department of Defense for military personnel and beneficiaries requiring...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes valued at $33,108.25 on August 4, 2025, with completion scheduled for August 5, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $51,797.40 to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML vials (10 ML units). This is a firm fixed-price delivery order with a completion date of August 4, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract was awarded through open competition with no set-aside designation, reflecting AmerisourceBergen's established capability to...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,388.17 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML Vial 10ML, a typhoid vaccine product. The award was issued on July 30, 2025, with an ultimate completion date of July 31, 2025, and represents a firm fixed price, competitively awarded contract with no set-aside designation. Performance will take place at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $2,759.60 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TYPHIM VI is a typhoid vaccine product, reflecting the company's role as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $6,899 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on July 28, 2025, with an ultimate completion date of July 29, 2025. This is a firm fixed price contract with no set-aside designation, awarded through open competition. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. TYPHIM VI is a typhoid vaccine used for immunization purposes across military and federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,043.03 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML vaccine vials on July 25, 2025, with completion expected by July 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $3,216.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML vial (10 mL) on July 18, 2025, with completion required by July 21, 2025. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside designation....
- The Defense Logistics Agency awarded a $8,632.90 firm fixed price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML vials with a 10ML capacity. The contract was competitively awarded without set-aside on August 9, 2025, with an ultimate completion date of August 11, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $3,827.28 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on July 31, 2025, with completion targeted for August 1, 2025. This firm fixed price delivery order, awarded without set-aside designation through competitive procurement, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- SPE2DB24D3015Indefinite Delivery Contract
- SPE2DB24D3015-SPE2DB25FGAMWDelivery Order
The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $6,697.07 on August 12, 2025, for TYPHIM VI 25 MCG/0.5 ML vials (10 mL units). This is a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The contract is scheduled for completion by August 13, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TYPHIM VI is a typhoid vaccine used for immunization within military and federal healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999 through December 2026. This comprehensive IDC serves as a global pharmaceutical support vehicle enabling the delivery of a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates its role as a critical pharmaceutical distributor for the Defense Health Agency and other federal healthcare entities, with a track record of fulfilling diverse medical procurement requirements through competitively awarded contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.7k | 8/12/25 |